0000908662-16-000389.txt : 20160114
0000908662-16-000389.hdr.sgml : 20160114
20160114161448
ACCESSION NUMBER: 0000908662-16-000389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160112
FILED AS OF DATE: 20160114
DATE AS OF CHANGE: 20160114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLAIR HENRY E
CENTRAL INDEX KEY: 0001021045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 161343116
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-01-12
0000907562
DYAX CORP
DYAX
0001021045
BLAIR HENRY E
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
1
0
0
0
Common Stock
2016-01-12
4
M
0
70000
2.94
A
421722
D
Common Stock
2016-01-12
4
M
0
50000
2.39
A
471722
D
Common Stock
2016-01-12
4
M
0
50000
2.09
A
521722
D
Common Stock
2016-01-12
4
M
0
50000
3.15
A
571722
D
Common Stock
2016-01-12
4
M
0
50000
2.09
A
621722
D
Common Stock
2016-01-12
4
M
0
25000
1.51
A
646722
D
Common Stock
2016-01-12
4
M
0
51414
2.06
A
698136
D
Common Stock
2016-01-12
4
M
0
117646
2.06
A
815782
D
Common Stock
2016-01-12
4
M
0
117646
2.06
A
933428
D
Common Stock
2016-01-12
4
M
0
66667
2.30
A
1000095
D
Common Stock
2016-01-12
4
M
0
16667
26.23
A
1016762
D
Common Stock
100
I
By wife
Stock Option (right to buy)
2.94
2016-01-12
4
M
0
70000
0
D
2016-07-03
Common Stock
70000
0
D
Stock Option (right to buy)
2.39
2016-01-12
4
M
0
50000
0
D
2019-02-11
Common Stock
50000
0
D
Stock Option (right to buy)
2.09
2016-01-12
4
M
0
50000
0
D
2019-05-14
Common Stock
50000
0
D
Stock Option (right to buy)
3.15
2016-01-12
4
M
0
50000
0
D
2020-05-06
Common Stock
50000
0
D
Stock Option (right to buy)
2.09
2016-01-12
4
M
0
50000
0
D
2021-05-12
Common Stock
50000
0
D
Stock Option (right to buy)
1.51
2016-01-12
4
M
0
25000
0
D
2022-05-09
Common Stock
25000
0
D
Stock Option (right to buy)
2.06
2016-01-12
4
M
0
51414
0
D
2017-06-20
Common Stock
51414
0
D
Stock Option (right to buy)
2.06
2016-01-12
4
M
0
117646
0
D
2017-07-02
Common Stock
117646
0
D
Stock Option (right to buy)
2.06
2016-01-12
4
M
0
117646
0
D
2018-02-13
Common Stock
117646
0
D
Stock Option (right to buy)
2.30
2016-01-12
4
M
0
66667
0
D
2023-05-09
Common Stock
66667
8333
D
Stock Option (right to buy)
26.23
2016-01-12
4
M
0
16667
0
D
2025-05-12
Common Stock
16667
8333
D
The options became fully exercisable on July 3, 2010.
The options became fully exercisable on May 14, 2009.
The options became fully exercisable on May 14, 2010.
The options became fully exercisable on May 12, 2011.
The options became fully exercisable on May 9, 2012.
The options became fully exercisable on May 9, 2013.
The options became fully exercisable on May 8, 2014.
The option becomes exercisable in thirty-six (36) substantially equal installments at the end of each monthly anniversary of the date of grant (May 9, 2013) for a period of thirty-five (35) months, with the 36th monthly installment to become exercisable as of the commencement of business on the date of the 2016 Annual Meeting of Stockholders at which such director is up for reelection or at which such director's term ends.
The option becomes exercisable in twelve (12) substantially equal installments on each monthly anniversary of the date of grant, May 12, 2015.
/s/ Stacie S. Aarestad as attorney-in-fact
2016-01-14